Remillard Carmelle V, Tigno Donna D, Platoshyn Oleksandr, Burg Elyssa D, Brevnova Elena E, Conger Diane, Nicholson Ann, Rana Brinda K, Channick Richard N, Rubin Lewis J, O'connor Daniel T, Yuan Jason X-J
Department of Medicine, University of California--San Diego, 9500 Gilman Dr., MC 0725, La Jolla, CA 92093-0725, USA.
Am J Physiol Cell Physiol. 2007 May;292(5):C1837-53. doi: 10.1152/ajpcell.00405.2006. Epub 2007 Jan 31.
The pore-forming alpha-subunit, Kv1.5, forms functional voltage-gated K(+) (Kv) channels in human pulmonary artery smooth muscle cells (PASMC) and plays an important role in regulating membrane potential, vascular tone, and PASMC proliferation and apoptosis. Inhibited Kv channel expression and function have been implicated in PASMC from patients with idiopathic pulmonary arterial hypertension (IPAH). Here, we report that overexpression of the Kv1.5 channel gene (KCNA5) in human PASMC and other cell lines produced a 15-pS single channel current and a large whole cell current that was sensitive to 4-aminopyridine. Extracellular application of nicotine, bepridil, correolide, and endothelin-1 (ET-1) all significantly and reversibly reduced the Kv1.5 currents, while nicotine and bepridil also accelerated the inactivation kinetics of the currents. Furthermore, we sequenced KCNA5 from IPAH patients and identified 17 single-nucleotide polymorphisms (SNPs); 7 are novel SNPs. There are 12 SNPs in the upstream 5' region, 2 of which may alter transcription factor binding sites in the promoter, 2 nonsynonymous SNPs in the coding region, 2 SNPs in the 3'-untranslated region, and 1 SNP in the 3'-flanking region. Two SNPs may correlate with the nitric oxide-mediated decrease in pulmonary arterial pressure. Allele frequency of two other SNPs in patients with a history of fenfluramine and phentermine use was significantly different from patients who have never taken the anorexigens. These results suggest that 1) Kv1.5 channels are modulated by various agonists (e.g., nicotine and ET-1); 2) novel SNPs in KCNA5 are present in IPAH patients; and 3) SNPs in the promoter and translated regions of KCNA5 may underlie the altered expression and/or function of Kv1.5 channels in PASMC from IPAH patients.
形成孔道的α亚基Kv1.5在人肺动脉平滑肌细胞(PASMC)中形成功能性电压门控钾离子(Kv)通道,在调节膜电位、血管张力以及PASMC增殖和凋亡中发挥重要作用。特发性肺动脉高压(IPAH)患者的PASMC中Kv通道表达和功能受到抑制。在此,我们报道,人PASMC和其他细胞系中Kv1.5通道基因(KCNA5)的过表达产生了一个15皮安的单通道电流以及一个对4-氨基吡啶敏感的大的全细胞电流。细胞外应用尼古丁、苄普地尔、correolide和内皮素-1(ET-1)均显著且可逆地降低了Kv1.5电流,而尼古丁和苄普地尔还加速了电流的失活动力学。此外,我们对IPAH患者的KCNA5进行了测序,鉴定出17个单核苷酸多态性(SNP);其中7个是新的SNP。5'上游区域有12个SNP,其中2个可能改变启动子中的转录因子结合位点,编码区域有2个非同义SNP,3'-非翻译区域有2个SNP,3'-侧翼区域有1个SNP。两个SNP可能与一氧化氮介导的肺动脉压降低相关。使用过芬氟拉明和苯丁胺的患者中另外两个SNP的等位基因频率与从未服用过食欲抑制剂的患者有显著差异。这些结果表明:1)Kv1.5通道受多种激动剂(如尼古丁和ET-1)调节;2)IPAH患者中存在KCNA5的新SNP;3)KCNA5启动子和编码区域的SNP可能是IPAH患者PASMC中Kv1.5通道表达和/或功能改变的基础。